Evaluation of the OARSI and OMERACT-OARSI set of responder criteria in patients treated with Hylan G-F 20 for knee osteoarthritis.

被引：0
|
作者：
Bell, MJ
Bellamy, N
Goldsmith, CH
Tugwell, P
Torrance, GW
Raynauld, JP
Polisson, R
Pericak, D
Walker, V
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Queensland, St Lucia, Qld 4067, Australia
[3] McMaster Univ, Hamilton, ON, Canada
[4] Univ Ottawa, Ottawa, ON, Canada
[5] Univ Montreal, Montreal, PQ, Canada
[6] Genzyme Corp, Cambridge, MA USA
[7] Innovus Res Inc, Burlington, ON, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1214
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [1] The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI
    Bellamy, N
    Bell, MJ
    Goldsmith, CH
    Pericak, D
    Walker, V
    Raynauld, JP
    Torrance, GW
    Tugwell, P
    Polisson, R
    OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (02) : 104 - 110
  • [2] OMERACT-OARSI initiative: OARSI set of responder criteria for osteoarthritis (OA) clinical trials revisited.
    Pham, T
    Van der Heijde, D
    Altman, RD
    Anderson, JJ
    Bellamy, N
    Hochberg, M
    Simon, L
    Strand, V
    Woodworth, T
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S158 - S158
  • [3] Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria
    Pham, T
    Van Der Heijde, D
    Lassere, M
    Altman, RD
    Anderson, JJ
    Bellamy, N
    Hochberg, M
    Simon, L
    Strand, V
    Woodworth, T
    Dougados, M
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1648 - 1654
  • [4] OMERACT-OARSI responder analysis in patients receiving etoricoxib, celecoxib or placebo for osteoarthritis.
    Bingham, Clifton O., III
    Bird, Steven
    Xu, Xia
    Smugar, Steven
    Tershakovec, Andrew M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S672 - S672
  • [5] Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study
    Conrozier, Thierry
    Bertin, Philippe
    Bailleul, Francois
    Mathieu, Pierre
    Charlot, Jacques
    Vignon, Eric
    Treves, Richard
    Chevalier, Xavier
    JOINT BONE SPINE, 2006, 73 (06) : 705 - 709
  • [6] Evaluation of the OMERACT-OARSI 2003 set of responder criteria for osteoarthritis clinical trials: Discriminant capacity, relation with patients'opinion
    Gossec, L
    Le Henanff, A
    Ravaud, P
    Dougados, M
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 360 - 360
  • [7] OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
    Pham, T
    van der Heijde, D
    Altman, RD
    Anderson, JJ
    Bellamy, N
    Hochberg, M
    Simon, L
    Strand, V
    Woodworth, T
    Dougados, M
    OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (05) : 389 - 399
  • [8] Comparing different therapeutic classes for the treatment of osteoarthritis of the knee: data from the OMERACT-OARSI responder criteria analysis
    Band, PA
    OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (05) : 449 - 449
  • [9] The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis
    Smith, Toby O.
    Hawker, Gillian A.
    Hunter, David J.
    March, Lyn M.
    Boers, Maarten
    Shea, Beverley J.
    Christensen, Robin
    Guillemin, Francis
    Terwee, Caroline B.
    Williamson, Paula R.
    Dodd, Susanna
    Roos, Ewa M.
    Loeser, Richard F.
    Schnitzer, Thomas J.
    Kloppenburg, Margreet
    Neogi, Tuhina
    Ladel, Christoph H.
    Kalsi, Gurdyal
    Kaiser, Ulrike
    Buttel, Thomas W.
    Ashford, Anne E.
    Mobasheri, Ali
    Arden, Nigel K.
    Tennant, Alan
    Hochberg, Marc C.
    de Wit, Maarten
    Tugwell, Peter
    Conaghan, Philip G.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 981 - 989
  • [10] EVALUATION OF THE EFFICACY OF INTRA-ARTICULAR INJECTIONS OF HYLAN G-F 20 IN PATIENTS WITH SYMPTOMATIC HIP OSTEOARTHRITIS, USING THE OARSI RESPONSE CRITERIA
    Conrozier, T.
    Bertin, P.
    Mathieu, P.
    Charlot, J.
    Bailleul, F.
    Treves, R.
    Vignon, E.
    Chevalier, X.
    RHEUMATOLOGY, 2003, 42 : 101 - 102
12345